Zyngenia Completes $15 million Series A Financing Extension
Posted on: September 8, 2010 by Eamon Beltran2 Comments »
Zyngenia Inc., a Gaithersburg, Md.-based biotherapeutics company that is developing antibody drugs, completed a $15 million Series A financing extension from New Enterprise Associates.


